资讯
1 天
News-Medical.Net on MSNNovel cancer immunotherapy approachcould complement existing CAR-T treatmentsResearchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.
The StrataQuest software was coupled with TissueFAXS, offering a convenient workflow that could automatically acquire up to ...
Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) ...
编者按:2025年美国临床肿瘤学会年会(ASCO)将于美国东部时间(GMT-5)5月30日至6月3日在芝加哥召开。作为全球规模最大、学术水平最高、最具权威性的国际肿瘤会议之一,2025年ASCO年会将汇聚顶级肿瘤专家、学者和行业领袖,共探肿瘤领域的前 ...
Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for ...
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
Data from the BEXMAB study marks a significant milestone for next-generation cancer immunotherapies TURKU, FI / ACCESS Newswire / April 24, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN), a ...
Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...
Cellular immunity is a protective immune process that involves the activation of phagocytes, antigen-sensitized cytotoxic T cells and the release of cytokines and chemokines in response to antigen.
Coya Therapeutics, Inc.’s COYA share price has surged by 6.94%, which has investors questioning if this is right time to sell ...
This study presents a valuable finding on the direct cytotoxic effects of DuoHexaBody-CD37 in diffuse large B-cell lymphoma, mediated via SHP-1 activation and antibody clustering, independent of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果